Literature DB >> 12845760

Comparison on the effects of three sex hormones on the fetal rat calvarial osteoblasts.

L Chen1, T Zeng, W Xia, L Ke.   

Abstract

17 beta-estradiol (E2), progesterone (P) and testosterone (T) were investigated for their effects on the proliferation and differentiation of primary rat calvarial osteoblasts in vitro. Rat calvarial osteoblasts were cultured with 10(-10) mol/L E2, 10(-9)-10(-6) mol/L P and 10(-10) mol/L T for 20 days. Cell proliferation was determined by 3H-thymidine incorporation and cell counting. Cell differentiation was examined by measuring alkaline phosphatase (ALP) activity, osteocalcin gene expression and production, bone nodule formation in different periods of culture. Our results showed that no effect of three sex hormones was observed on cell proliferation, but, the responses of cell differentiation to the hormones were more or less different. Among these three hormones used in this study, P appeared to have multi-stimulating effect on cell differentiation. Effect of T seemed not so significant as that of P on cell differentiation. Although ALP activity and osteocalcin production were increased significantly by T, it had slight effect on osteocalcin mRNA and bone nodule formation. Besides, E2 did not demonstrate any effect on cell differentiation. It is concluded that the proliferation of rat calvarial osteoblasts was independent of the presence of sex hormones. However, the differentiation of these cells were stimulated in different levels and to different extent either by P or T. P appeared to be a multi-stimulator on differentiation of such cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12845760     DOI: 10.1007/bf02887679

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  11 in total

1.  Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells.

Authors:  P E Keeting; R E Scott; D S Colvard; I K Han; T C Spelsberg; B L Riggs
Journal:  J Bone Miner Res       Date:  1991-03       Impact factor: 6.741

2.  17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.

Authors:  T K Gray; T C Flynn; K M Gray; L M Nabell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  ALP induction by beta-glycerophosphate during the non-mineralization phase in vitro.

Authors:  L Chen; J Schøller; N T Foged
Journal:  J Tongji Med Univ       Date:  1996

4.  Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations.

Authors:  C G Bellows; J E Aubin; J N Heersche; M E Antosz
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

5.  Evidence of estrogen receptors in normal human osteoblast-like cells.

Authors:  E F Eriksen; D S Colvard; N J Berg; M L Graham; K G Mann; T C Spelsberg; B L Riggs
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

6.  Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells.

Authors:  C Kasperk; R Fitzsimmons; D Strong; S Mohan; J Jennings; J Wergedal; D Baylink
Journal:  J Clin Endocrinol Metab       Date:  1990-11       Impact factor: 5.958

Review 7.  Cytokines and estrogen in bone: anti-osteoporotic effects.

Authors:  M C Horowitz
Journal:  Science       Date:  1993-04-30       Impact factor: 47.728

Review 8.  Transforming growth factor-beta gene family members and bone.

Authors:  M Centrella; M C Horowitz; J M Wozney; T L McCarthy
Journal:  Endocr Rev       Date:  1994-02       Impact factor: 19.871

9.  Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro.

Authors:  B A Scheven; C A Damen; N J Hamilton; H J Verhaar; S A Duursma
Journal:  Biochem Biophys Res Commun       Date:  1992-07-15       Impact factor: 3.575

10.  Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro.

Authors:  C G Bellows; J E Aubin
Journal:  Dev Biol       Date:  1989-05       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.